IL17A and hepatocellular carcinoma: It was determined that Pro-hep attenuated Th17 cell polarization within HCC tumors and downregulated the production of the pro-inflammatory vascular growth factor IL-17, thereby impeding HCC tumor progression (Figure 2F).